Advertisement

More Support for Bariatric Surgery for Type 2 Diabetes — Physician’s First Watch

Medical News |
June 5, 2014

More Support for Bariatric Surgery for Type 2 Diabetes

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and Lorenzo Di Francesco, MD, FACP, FHM

Two randomized trials in JAMA Surgery add to the growing evidence favoring bariatric surgery for treating obese patients with type 2 diabetes.

In the first, 38 obese adults receiving diabetes medications were randomized either to undergo Roux-en-Y gastric bypass or to participate in an intensive multidisciplinary regimen that included medication, dietary adjustment, exercise, cognitive-behavioral therapy, and group education. At 1 year, the surgery group achieved a higher rate of glycemic control than the interdisciplinary group (58% vs. 16%).

In the second study, 69 obese, diabetic adults were randomized to undergo Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, or an intensive lifestyle weight loss intervention. At 1 year, the bypass group had lost the most weight. Rates of partial and complete diabetes remission were 50% and 17%, respectively, in the bypass group and 27% and 23% in the banding group. No lifestyle patients achieved partial or complete remission.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement